CB30900
CB30900 is an inhibitor for thymidylate synthase with an IC50 of 0.2 μM. CB30900 exhibits cytotoxicity in W1L2 with an IC50 of 0.13 μM.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 145788-82-5
- Fòrmula: C31H32FN5O9
- Peso molecular:637.61
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Chemical Information
-
No. CAS 145788-82-5
-
Peso molecular 637.61
-
Fòrmula C31H32FN5O9
-
SMILES
O=C1C2=CC(CN(C3=CC(F)=C(C=C3)C(N[C@H](C(O)=O)CCC(N[C@@H](C(O)=O)CCC(O)=O)=O)=O)CC#C)=C(C)C=C2NC(C)=N1
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Walton MI, et al., Preclinical pharmacology of CB30900, a novel dipeptide inhibitor of thymidylate synthase, in mice. J Pharmacol Exp Ther. 1996 May;277(2):909-16. [Content Brief]
[2]. Aherne GW, et al., Immunoreactive dUMP and TTP pools as an index of thymidylate synthase inhibition; effect of tomudex (ZD1694) and a nonpolyglutamated quinazoline antifolate (CB30900) in L1210 mouse leukaemia cells. Biochem Pharmacol. 1996 May 17;51(10):1293-301 [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)